Brazil Breaks Patent On Merck's AIDS Drug
Brazil's president has signed a compulsory license that overrides Merck & Co. Inc.'s patent on HIV/AIDS drug Efavirenz so that the country can import a generic version of the drug from...To view the full article, register now.
Already a subscriber? Click here to view full article